GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 79 filers reported holding GLYCOMIMETICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,278 | -65.0% | 3,395 | -15.9% | 0.00% | – |
| Q4 2022 | $12,235 | +307.8% | 4,038 | -20.2% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 5,063 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -98.8% | 5,063 | -97.7% | 0.00% | -100.0% |
| Q1 2022 | $248,000 | -50.1% | 217,116 | -37.2% | 0.00% | 0.0% |
| Q4 2021 | $497,000 | -34.2% | 345,452 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $755,000 | -5.3% | 344,623 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $797,000 | -22.7% | 343,572 | +0.3% | 0.00% | -50.0% |
| Q1 2021 | $1,031,000 | -33.6% | 342,631 | -17.0% | 0.00% | -33.3% |
| Q4 2020 | $1,553,000 | +1.2% | 412,998 | -17.4% | 0.00% | -25.0% |
| Q3 2020 | $1,535,000 | -18.5% | 499,915 | -0.2% | 0.00% | -20.0% |
| Q2 2020 | $1,883,000 | +85.7% | 500,908 | +12.7% | 0.01% | +66.7% |
| Q1 2020 | $1,014,000 | +39.1% | 444,639 | +222.6% | 0.00% | +50.0% |
| Q4 2019 | $729,000 | +4456.2% | 137,828 | +14672.6% | 0.00% | – |
| Q4 2017 | $16,000 | +1500.0% | 933 | +805.8% | 0.00% | – |
| Q2 2015 | $1,000 | – | 103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $5,220,000 | 0.73% |
| NEA Management Company, LLC | 4,764,440 | $8,290,126 | 0.63% |
| Artal Group S.A. | 8,589,064 | $14,945 | 0.46% |
| BVF INC/IL | 9,544,262 | $16,607,016 | 0.46% |
| Sargent Investment Group, LLC | 108,000 | $187,920 | 0.05% |
| Intellectus Partners, LLC | 73,475 | $127,847 | 0.04% |
| XTX Topco Ltd | 29,998 | $52,197 | 0.01% |
| AXA S.A. | 1,631,509 | $2,838,826 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,149,656 | $1,999 | 0.01% |
| TOBIAS FINANCIAL ADVISORS, INC. | 15,000 | $26,100 | 0.01% |